<html>
<head>PUBMED IDs for ARR2</head>
<body bgcolor='#C5F0F2'><h1>ARR2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11108285/'>A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo.</a> December 7  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11418617/'>Arrestin specificity for G protein-coupled receptors in human airway smooth muscle.</a> June 22  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11535706/'>Use of the probasin promoter ARR2PB to express Bax in androgen receptor-positive prostate cancer cells.</a> September 6  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11571575/'>Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.</a> September 26  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12884364/'>Prostate-specific antitumor activity by probasin promoter-directed p202 expression.</a> July 29  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14695195/'>Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate.</a> December 26  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15014127/'>Novel dominant rhodopsin mutation triggers two mechanisms of retinal degeneration and photoreceptor desensitization.</a> March 12  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15229631/'>Highly specific transgene expression mediated by a complex adenovirus vector incorporating a prostate-specific amplification feedback loop.</a> July 2  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16778194/'>EZC-prostate models offer high sensitivity and specificity for noninvasive imaging of prostate cancer progression and androgen receptor action.</a> June 17  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18395839/'>Temporally controlled prostate epithelium-specific gene alterations.</a> April 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20514017/'>Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence.</a> August 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22416137/'>Neurotensin-induced proinflammatory signaling in human colonocytes is regulated by β-arrestins and endothelin-converting enzyme-1-dependent endocytosis and resensitization of neurotensin receptor 1.</a> July 3  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22844460/'>Doxycycline regulated induction of AKT in murine prostate drives proliferation independently of p27 cyclin dependent kinase inhibitor downregulation.</a> December 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22844456/'>Tristetraprolin inhibits poly(A)-tail synthesis in nuclear mRNA that contains AU-rich elements by interacting with poly(A)-binding protein nuclear 1.</a> December 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23449888/'>ARF represses androgen receptor transactivation in prostate cancer.</a> September 12  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24727894/'>δ-Catenin, a Wnt/β-catenin modulator, reveals inducible mutagenesis promoting cancer cell survival adaptation and metabolic reprogramming.</a> June 18  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24785255/'>Targeted BikDD expression kills androgen-dependent and castration-resistant prostate cancer cells.</a> April 22  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24898255/'>Endothelin-converting enzyme 1 and β-arrestins exert spatiotemporal control of substance P-induced inflammatory signals.</a> October 7  2014<br></body></html>
